Breast cancer (BC) is a heterogeneous disease that can be classified into subtypes based on gene expression profiles or histological presentation of levels/presence of hormone or growth factor receptors, e.g., estrogen receptor (ER), progesterone receptor (PR), and epidermal growth factor receptor HER2/neu [1, 2]. The gene discussed is ERBB2; the disease is breast carcinoma.